We also observe that TOX level in the TI T cells inversely correlates with overall survival and anti-PD-1 response in human melanoma and NSCLC, which suggest that TOX expression in the TI T cells can be used for patient stratification before anti-tumor immunotherapy, such as anti-PD-1 treatment. This evidence concerns the gene PDCD1 and melanoma.